Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

RECRUITING

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

Lead Sponsor:

Canadian Cancer Trials Group

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Conditions:

Chronic Lymphocytic Leukemia

Small Lymphocytic Lymphoma

Eligibility:

All Genders

18+ years

Brief Summary

Utilization data will be collected from all patients entered on the trial at Canadian centres from the time of registration until death, removal from study, or completion of 10 years of follow-up. Pr...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patient must be eligible for the core CLC3/S1925 protocol.
  • Patient consent must be appropriately obtained in accordance with applicable local and regulatory requirements. Each patient must sign a consent form prior to enrollment in the trial to document their willingness to participate.
  • Patient is able (i.e. sufficiently fluent) and willing to complete the quality of life and/or health utility questionnaires in either English or French. The baseline assessment must be completed within required timelines, prior to enrollment. Inability (lack of comprehension in English or French, or other equivalent reason such as cognitive issues or lack of competency) to complete the questionnaires will not make the patient ineligible for the study. However, ability but unwillingness to complete the questionnaires will make the patient ineligible.
  • Patients must be accessible for treatment and follow-up. Investigators must assure themselves the patients enrolled on this trial will be available for complete documentation of the treatment, adverse events, and follow-up.

Exclusion

    Key Trial Info

    Start Date :

    January 27 2023

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 1 2028

    Estimated Enrollment :

    247 Patients enrolled

    Trial Details

    Trial ID

    NCT05371808

    Start Date

    January 27 2023

    End Date

    October 1 2028

    Last Update

    April 17 2025

    Active Locations (8)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (8 locations)

    1

    BCCA - Vancouver

    Vancouver, British Columbia, Canada, V5Z 4E6

    2

    CancerCare Manitoba

    Winnipeg, Manitoba, Canada, R3E 0V9

    3

    Regional Health Authority B, Zone 2

    Saint John, New Brunswick, Canada, E2L 4L2

    4

    QEII Health Sciences Centre

    Halifax, Nova Scotia, Canada, B3H 1V7